Platelet rich plasma can naturally induce early repair of muscles and ligaments in case of orthopaedic wounds, degenerative knee ligament, skin rejuvenation and restoration process by using platelets from patients’ blood that is centrifuged. Awareness among ageing population looking for both cosmetic and non-cosmetic benefits and availability of skilled professional performing the procedure is fuelling the growth of platelet-rich plasma market in Europe.
Europe platelet-rich plasma market is expected to reach $ 171.1 million by the end of 2026 and register a CAGR of 9.2% during the forecast period of 2018-2026.

Insight to Europe Platelet-Rich Plasma Market
Europe platelet-rich plasma market holds gigantic growth potential and is expected to expand at 9.2% CAGR over 2018-2026. As per senior research consultant at FutureWise’ speculation, market players in Europe platelet-rich plasma market are expected to witness generous growth opportunities over the next few years. However, the growth is prone to pending approvals for numerous investigational applications of PRP therapy.

Market Differentiators Trending the Europe Platelet-Rich Plasma Market
Europe market for platelet-rich plasma kits and systems is dominated by Korea based manufacturers of kits & systems.
These Korean companies have a distribution partnership with domestic distributors, pharmacies and GPOs for distribution of their products in EU5.

Competition Overview
> Although Europe PRP market is dominated by Korean players, regional players such as Glofinn oy (Finland), Regen Lab SA (Switzerland), etc. have a considerable volume share.
> The overall market competition is moderate and the market is fragmented with a large number of global and regional players operating. Despite the fragmented market, penetration in the market is not limited by competition.
> Among all applications of platelet-rich plasma, cosmetic & aesthetic application segment led the Europe market in terms of revenue, in 2017 and this trend is expected to continue throughout the forecast period. Due to the high penetration of PRP treatments in the cosmetic industry, cosmetic/dermatology/trichology clinics end-user segment clearly dominated the Europe platelet-rich plasma market.
> Among EU5 countries, Germany dominated the Europe market in 2017 with 33.2% revenue share. Manufacturing industry for platelet-rich plasma kits and systems is concentrated in Germany, which in part is attributed to the dominance of Germany in Europe.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=136&page=requestsample
• Europe Platelet-Rich Plasma Market Segmentation
Europe platelet-rich plasma market is segmented, by sales channel, end-user and applications. Being low margin product, direct sales channel sub-segment of PRP kits product type is at the forefront. All clinics segments collectively experience high demand for PRP kits in Europe and hence are major end-users. Cosmetic applications, including skin rejuvenation, scar treatment, skin firming & whitening, fat grafting, hair loss treatment etc pose stupendous demand for PRP kits.
• In the U.K., PRP treatment industry is well established. However, there's a limited presence of domestic manufacturers of PRP kits in U.K. Hence, PRP kits are availed in the country through distributors that have a partnership with manufacturing companies.
• Key Market Drivers for Europe Platelet-Rich Plasma Market:

• > Growing Popularity of PRP as Surgical Adjuvant
Introduction of a more sophisticated concept of tissue regeneration prompted the tissue regeneration applications of PRP, and PRP is now emerging as a glorious instrument of regenerative medicine
• > Frequently Growing Applications of PRP
Emerging application areas for PRP include pain relief, ortho-biologics, musculoskeletal and sports medicine, tendinopathy treatment, breast reconstruction, periodontal tissue engineering (dentistry) etc. and the list is continuously growing
•
• Major Market Challenges Faced by Europe Platelet-Rich Plasma Market

> Non-Approvals for Therapeutic Use
PRP therapy for medical use is largely debated, as clinical trials across Europe and the United States are showing conflicting results
• > Conflicting Opinions Among Clinicians
Because the PRP therapy is unapproved by the regulatory authorities of Europe, there exists confusion among clinicians whether to use PRP procedures in their office or not
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=136&page=askfordiscount

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Europe plasma rich platelets market, by sales channel, by end-user, and application
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size in Europe
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1. Section 1
1.1. About Us
1.2. Overall Research Process
1.3. Research Methodology
1.4. Report Assumptions and Acronyms
1.5. Forecasting Factors and Assumptions
2. Section 2
2.1. Market Purview
2.1.1. Report Description
2.1.2. Market Definition and Scope
2.2. Executive Summary: Platelet-rich Plasma Market
2.2.1. Top 3 Market Findings
2.2.2. Top 3 Market Opportunity
2.2.3. Market Snippet By Region/Country
2.2.4. Market Snippet By Product Type
2.2.5. Market Snippet By Applications
2.3. Coherent Opportunity Map (COM)
3. Section 3
3.1. Market Dynamics, Regulations, and Trends Analysis
3.1.1. Market Dynamics
3.1.1.1. Drivers
3.1.1.1.1. Supply Side Drivers
3.1.1.1.2. Demand Side Drivers
3.1.1.1.3. Economic Drivers
3.1.1.2. Restraints
3.1.1.3. Market Opportunities
3.1.1.4. Key Trends
3.2. Porter’s Five Force Analysis: New Product Launch Perspective
3.3. Products Application Analysis
3.4. U.K. Platelet-Rich Plasma Market End User Analysis
4. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019 – 2026, By Product Type
4.1. Key Findings
4.2. Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Product Type (2019 ^ 2026)
4.3. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Product Type
4.3.1. Platelet-Rich Plasma Systems
4.3.2. PRP Kits & Consumables
4.3.2.1. Direct Sales
4.3.2.2. Distributor Sales
4.3.2.3. Group Purchasing Organizations
4.4. Long Term ROI Segments, By Product Type
5. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019 – 2026, By Application
5.1. Key Findings
5.2. Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Application (2019 & 2026)
5.3. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Applications
5.3.1. Dermatology/Plastic Surgery
5.3.2. Orthopedics/Rehabilitation medicine
5.3.3. Dentistry
5.3.4. Ophthalmology
5.3.5. Research and Development
5.3.6. Veterinary
5.4. Long Term ROI Segments, By Applications
6. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019 – 2026, By End User
6.1. Key Findings
6.2. Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By End Users
6.3. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By End Users
6.3.1. Physician's office/Private Practice
6.3.2. Hospitals
6.3.3. Orthopedic Clinics
6.3.4. Cosmetic/dermatology/Trichology Clinics
6.3.5. Academic & Research Institutes
6.4. Long Term ROI Segments, By End Users
7. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019 – 2026, By Country
7.1. Introduction & Key Findings
7.2. Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Country
7.3. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Country
7.3.1. Germany
7.3.2. Italy
7.3.3. France
7.3.4. U.K.
7.3.5. Spain
7.3.6. Rest of the Europe
7.4. Long Term ROI Segments, By Region
8. Germany Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
8.1. Key Findings
8.2. Germany Platelet-rich Plasma Market Value Share Analysis
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.3.1. Platelet-Rich Plasma Systems
8.3.2. PRP Kits & Consumables
8.3.2.1. Direct Sales
8.3.2.2. Distributor Sales
8.3.2.3. Group Purchasing Organizations
8.4. Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.4.1. Dermatology/Plastic Surgery
8.4.2. Orthopedics/Rehabilitation medicine
8.4.3. Dentistry
8.4.4. Ophthalmology
8.4.5. Research and Development
8.4.6. Veterinary
8.5. End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.5.1. Physician's office/Private Practice
8.5.2. Hospitals
8.5.3. Orthopedic Clinics
8.5.4. Cosmetic/dermatology/Trichology Clinics
8.5.5. Academic & Research Institutes
8.6. Germany Platelet-rich Plasma Market Trends
9. Italy Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
9.1. Key Findings
9.2. Italy Platelet-rich Plasma Market Value Share Analysis
9.2.1. By Product Type
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.3.1. Platelet-Rich Plasma Systems
9.3.2. PRP Kits & Consumables
9.3.2.1. Direct Sales
9.3.2.2. Distributor Sales
9.3.2.3. Group Purchasing Organizations
9.4. Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.4.1. Dermatology/Plastic Surgery
9.4.2. Orthopedics/Rehabilitation medicine
9.4.3. Dentistry
9.4.4. Ophthalmology
9.4.5. Research and Development
9.4.6. Veterinary
9.5. End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.5.1. Physician's office/Private Practice
9.5.2. Hospitals
9.5.3. Orthopedic Clinics
9.5.4. Cosmetic/dermatology/Trichology Clinics
9.5.5. Academic & Research Institutes
9.6. Italy Platelet-rich Plasma Market Trends
10. France Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
10.1.Key Findings
10.2.France Platelet-rich Plasma Market Value Share Analysis
10.2.1. By Product Type
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.3.1. Platelet-Rich Plasma Systems
10.3.2. PRP Kits & Consumables
10.3.2.1. Direct Sales
10.3.2.2. Distributor Sales
10.3.2.3. Group Purchasing Organizations
10.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.4.1. Dermatology/Plastic Surgery
10.4.2. Orthopedics/Rehabilitation medicine
10.4.3. Dentistry
10.4.4. Ophthalmology
10.4.5. Research and Development
10.4.6. Veterinary
10.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.5.1. Physician's office/Private Practice
10.5.2. Hospitals
10.5.3. Orthopedic Clinics
10.5.4. Cosmetic/dermatology/Trichology Clinics
10.5.5. Academic & Research Institutes
10.6.France Platelet-rich Plasma Market Trends
11. U.K. Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
11.1.Key Findings
11.2.U.K. Platelet-rich Plasma Market Value Share Analysis
11.2.1. By Product Type
11.2.2. By Application
11.2.3. By End User
11.2.4. By Country
11.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.3.1. Platelet-Rich Plasma Systems
11.3.2. PRP Kits & Consumables
11.3.2.1. Direct Sales
11.3.2.2. Distributor Sales
11.3.2.3. Group Purchasing Organizations
11.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.4.1. Dermatology/Plastic Surgery
11.4.2. Orthopedics/Rehabilitation medicine
11.4.3. Dentistry
11.4.4. Ophthalmology
11.4.5. Research and Development
11.4.6. Veterinary
11.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.5.1. Physician's office/Private Practice
11.5.2. Hospitals
11.5.3. Orthopedic Clinics
11.5.4. Cosmetic/dermatology/Trichology Clinics
11.5.5. Academic & Research Institutes
11.6.U.K. Platelet-rich Plasma Market Trends
12. Spain Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
12.1.Key Findings
12.2.Spain Platelet-rich Plasma Market Value Share Analysis
12.2.1. By Product Type
12.2.2. By Application
12.2.3. By End User
12.2.4. By Country
12.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.3.1. Platelet-Rich Plasma Systems
12.3.2. PRP Kits & Consumables
12.3.2.1. Direct Sales
12.3.2.2. Distributor Sales
12.3.2.3. Group Purchasing Organizations
12.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.4.1. Dermatology/Plastic Surgery
12.4.2. Orthopedics/Rehabilitation medicine
12.4.3. Dentistry
12.4.4. Ophthalmology
12.4.5. Research and Development
12.4.6. Veterinary
12.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.5.1. Physician's office/Private Practice
12.5.2. Hospitals
12.5.3. Orthopedic Clinics
12.5.4. Cosmetic/dermatology/Trichology Clinics
12.5.5. Academic & Research Institutes
12.6.Spain Platelet-rich Plasma Market Trends
13. Rest of the Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
13.1.Key Findings
13.2.Rest of the Europe Platelet-rich Plasma Market Value Share Analysis
13.2.1. By Product Type
13.2.2. By Application
13.2.3. By End User
13.2.4. By Country
13.2.5. Rest of the Europe stitutes
13.3.Market Influencing Factors
14. Europe Platelet-rich Plasma Market Competition
14.1.Competition Dashboard
14.2.Competitive Landscape
14.2.1. Key Development Strategies
14.2.2. Market Tier Structure Analysis
14.2.3. Competitors Concentration, By Region
14.3.Platelet-rich Plasma Product Life Cycle Positioning
14.4.Company Profiles
14.4.1. Terumo BCT
14.4.1.1. Overview
14.4.1.2. Product Portfolio
14.4.1.3. Financial Performance
14.4.1.4. Peer Comparison & 3C marketing equation
14.4.1.5. Company Strategy & Channel Management
14.4.2. Zimmer Biomet
14.4.2.1. Overview
14.4.2.2. Product Portfolio
14.4.2.3. Financial Performance
14.4.2.4. Peer Comparison & 3C marketing equation
14.4.2.5. Company Strategy & Channel Management
14.4.3. NeoGenesis Co. Ltd
14.4.3.1. Overview
14.4.3.2. Product Portfolio
14.4.3.3. Financial Performance
14.4.3.4. Peer Comparison & 3C marketing equation
14.4.3.5. Company Strategy & Channel Management
14.4.4. Glofinn oy Overview
14.4.4.1. Product Portfolio
14.4.4.2. Financial Performance
14.4.4.3. Peer Comparison & 3C marketing equation
14.4.4.4. Company Strategy & Channel Management
14.4.5. T Biotechnology (T Lab)
14.4.5.1. Overview
14.4.5.2. Product Portfolio
14.4.5.3. Financial Performance
14.4.5.4. Peer Comparison & 3C marketing equation
14.4.5.5. Company Strategy & Channel Management
14.4.6. Regen Lab SA
14.4.6.1. Overview
14.4.6.2. Product Portfolio
14.4.6.3. Financial Performance
14.4.6.4. Peer Comparison & 3C marketing equation
14.4.6.5. Company Strategy & Channel Management
14.4.7. SDD Medical Group Ltd Overview
14.4.7.1. Product Portfolio
14.4.7.2. Financial Performance
14.4.7.3. Peer Comparison & 3C marketing equation
14.4.7.4. Company Strategy & Channel Management
14.4.8. IntraVita International Limited Overview
14.4.8.1. Product Portfolio
14.4.8.2. Financial Performance
14.4.8.3. Peer Comparison & 3C marketing equation
14.4.8.4. Company Strategy & Channel Management
14.4.9. Exactech Inc.
14.4.9.1. Overview
14.4.9.2. Product Portfolio
14.4.9.3. Financial Performance
14.4.9.4. Peer Comparison & 3C marketing equation
14.4.9.5. Company Strategy & Channel Management
14.4.10. Arthrex Inc.
14.4.10.1. Overview
14.4.10.2. Product Portfolio
14.4.10.3. Financial Performance
14.4.10.4. Peer Comparison & 3C marketing equation
14.4.10.5. Company Strategy & Channel Management
14.4.11. Biotechnology Institute (bti)
14.4.11.1. Overview
14.4.11.2. Product Portfolio
14.4.11.3. Financial Performance
14.4.11.4. Peer Comparison & 3C marketing equation

Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com